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From The Editor
by Steve Lundy

This editorial is important to me for several reasons. First
it heralds the end of my clinical clerkship and second, this
will be my last issue as editor of The Medical Journal. Both
clinical clerkship and the editorial position have had their
ups and downs, and both have had their elements of
humour.
"People" are what make medicine so much fun, and I
have seen my share of "different" people this year. I will
always fondly recall one evening at St. Joseph's emergency
that I spent with an obese psychotic patient who was receiving "messages" from Audie Murphy (a familiar name if you
watch old cowboy movies). This patient's agitation was so
great that she could not be kept in an examining room . Consequently, she spent a whole hour (prior to her transfer to
LPH) walking in a big square about St. Joseph's emergency,
receiving messages the whole time from Audie Murphy. I
spent one hour of my clerkship walking behind this lady
making sure she and other patients came to no harm - not
my idea of what medicine would entail when I first applied
three years ago.
Family medicine was a "gold mine" when it came to encountering unusual patients. One patient in particular
typified this. He was a skinny middle-aged fellow with a
complaint of itching perianally and underneath his penis. It
sounded straightforward to me but I asked a few more questions.
"Do you have any more problems sir?"
"Yes, I have had some funny feelings in my stomach".
The patient delivered these words tentatively with a whimsical look on his face . He then proceeded to deny any G-1
complaints other than this "funny feeling". My next question was no more earthshaking than the first.

"Any more problems?"
"Yes, I've had some cold sweats over the last few weeks."
These "cold sweats" turned out to be elusive as Liberals
west of Ontario (or Windsor doctors who haven't opted out
of O.H.I.P .). I gave it one more try.
"Are these the only problems you have?"
"Well, no. I have had a pulling feeling in my eyes the last
few weeks ."
Surprisingly, this patient did have a perianal rash. As to
his other problems, who know~?
This past year has been very educational. Let me share a
few aphorisms with you based on a year's experience. If you
wear white shoes you are halfway to being a surgeon. A
flashy sport's car is equivalent to wearing white shoes.
Psychiatrists smoke pipes. Psychologists smoke dope.
Medical students get married-surgical and obstetrical
residents get divorced. "Sandwich rounds" are the best
teaching rounds. Lab medicine induces fatigue (as do the
first two years of medicine). Rashes are not meant to be
identified and can always have steroid cremes applied.
Steroid cremes are not known to cause cancer (yet!). An
endorphin-a-day will keep the blues away (prostaglandins
used to be capable of this). Everyone deserves a trial of
Cimetidine. Every female patient has prolapsing mitral
valve syndrome until proven otherwise.
After these few "gems" let me say that this issue of the
Journal is a good one. It includes a diversity of articles including two very comprehensive and excellent articles -Dr.
Yuzbe's review of contraception including what the future
holds and Dr. Gowdey's look at the exciting new field of
"endorphins". We hope you will read and enjoy this issue
of the Journal.
by Steve Lundy

The University of West~ro Ontario Medical Journal is published four times per year by the
stud.ents of the UWO Medical School. Established in 1930. Subscription rate is $6.00 per year.
Notify the Jo~nal of any change of .address promptly. All Correspondence should be directed
to UWO.Med.ical Journal, Healt~ Sc~ences, UWO ., London, Ontario, Canada. Layout is done
by Denn~s Matthe~s and t.ypesettmg IS done by Marilyn Hull of Supreme Typesetting Ltd.
C?ntnbuted articles will b~ ~elcomed by the editorial board. Content may range from
med1~al research to relevant fictiOn. Photographs and drawings will be accepted. All articles
submitted should be typewritten and double spaced.
!he. contents of this journal may not be reproduced without the written permission of the
edltonal board.
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Depression Today
Confident Clinical Office Management
SCIENTIFIC PROGRAM:
DEPRESSION TODAY is a learning system for continuing medical education . Its broad goal is to help physicians
gain the knowledge needed to provide quality care to patients with depression .
Highly practical in concept, the system focuses on depression issues that are directly applicable to a physician's
everyday clinical practice.
This program incorporates film presentations and monographs having self-evaluation tests .

PART 1: RECOGNIZING AND DIAGNOSING DEPRESSION- 30 Minutes
This unit provides a practical approach which can be integrated into the routine interview and the examination
of patients.

PART 2: MANAGINu • rfE ACUTE EPISODE AND FOLLOW-UP PHASE- 30 Minutes
In this unit, physicians learn how to treat depression using currently accepted pharmacotherapy and psychotherapeutic measures.

PART 3: SPECIAL CASES IN THE PHARMACOLOGIC MANAGEMENT OF DEPRESSION -

30 Minutes

This unit, of particular interest to psychiatrists as well as to other physicians , deals with pharmacologic management of the more complex cases of depression .

ACCREDITATION:
Approved for 1 credit hour in Category 1 for the Physician 's Recognition Award of the American Medical Association for each film and 9 credit hours for completion of the monographs .

Merrell

THE WM. S. MERRELL COMPANY
Division of Richardson-Merrell (Canada) Ltd.
2 Norelco Drive, Weston, Ontario M9L 1R9

To schedule this Depression Program for your
next meeting CALL OR WRITE
ED KENNY
31 Park Avenue
St. Thomas

631-4079
Merrell Medical Specialities include
AVC, Bendectin, Bentylol, Biogastrone, Cepacol, Duogastrone,
Tace, Tenuate, Chronulac, Cephulac, Norpramin
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Medical Elective in Taiwan
by David James Mathies
Meds 79
This past year, the Foreign Medical
Elective Programme at Western attracted
many members of the Fourth Year
class. Opportunities to observe the practice of medicine were found in places
such as Tanzania, Sumatra, Scotland,
New Zealand, New Guinea, Bangladesh,
India , and in many different states of
the United States . I myself, along with
my wife Victoria, spent three months at
a mission hospital in Hualien, Taiwan .
In the rest of this article I would like to
touch on some of the highlights of our
experiences there .
For the average medical student , even
with the recent airfare "warfare", long
distance travelling costs are prohibitively
expensive . Fortunately for us some
generous funding for the elective came
from the Mennonite Medical Association. In addition to considerable financial assistance, they also arranged my
placement at the Mennonite Christian
Hospital in Hualien where we were provided in an apartment on the hospital
compound absolutely free.
Language difficulties became immediately apparent. My wife attempted
to ease the problem in one way by providing English lessons to nurses four
days a week, lessons the hospital administration enthusiastically supported. I
was left to struggle to communicate
through interpreters. The medical staff
was made up of North Americans
primarily, but the residents and internes
were Chinese whose English was only
just comprehensible. Nurses, and of
course, patients, could not speak any
English . Indeed, many patients did not
even speak Mandarin , the official
language in Taiwan since 1949 . As a
result situations often arose where more
THE OOC.."Tb~ 70L-D
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than one interpreter was needed . A simple question like " Do you smoke?"
resulted in much discussi on at each step
and a final answer " No ." This left me
wondering what priceless data was being
lost at each step in the tran slation process. This led to frustration, a feeling I
solved by participating in the hospital 's
publi c health program and Mobile
clinics .
The hospital offered services in all of
the major special ties except psychiatry
(it didn't seem to exist as a di scipline
except in the largest cities). I spent
about equal time in each, interspersed
with a great deal of time on Mobile
clinics. The public health nurses were
concentrating their efforts on parasi tes
and birth control and I found that
although my usefulness in the hospital
was limited , I could be of considerable
aid to them in the vi llages. Incidentally ,
I think it should be kept in mind when
consi dering a foreign elective how much
language barriers can prevent participation . By the time a medical st udent is in
fourth year , he or she probably would
like a little more than just observer
status.
The public health program I became
involved with proved to be particularly
enjoyable because of the necessi ty to
work with people in their hom es, rather
than in the conspicuously "Western"
edifice, the hospital. On one occasion
we were fortunate to be invited to a
wedding feast, although the bride and
groom were total strangers to ourselves .
Nevertheless we became the honoured
guests,
and
were
treated
to
a
gastronomic delight of unfamiliar but
highly palatable foods. These included
cow's stomach soup, squid, another

srop
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soup in which a duck was swimming
whole (head, feet and all!), sweet bean
and rice dishes, and hot spicy octopus.
Such
spontaneous
friendliness
and
generosity was commonplace. More than
once a compliment or admiring glance
resulted in an instant gift.
Politically, Taiwan was an interesting
place in which to live. The recent
developments in Sino-American relations
have I'm sure attracted considerable
alarm in Taiwan. The fact that both
Chinas consider the other part of
themselves and that each is determined
to annex the other will surely complicate
the issues . Taiwan, a country approximately the size of Vancouver Island,
with a population close to seventeen
million , seems to be convinced that one
day it will recover the mainland and
restore it to their particular form of
democracy . At least the daily newspaper
there emphatically stated it was possible.
Wherever one travelled expertly trained
soldiers could even be seen marching
and practicing their martial arts in a
kind of frightening ballet. During my
stay I found it increasingly easy to sympathize with them, as recovery meant
for many a return to homes and
relatives left behind during the revolution . What will be the outcome of
China's ideological struggle is certainly
not yet a foregone conclusion.
The lessons gained from this elective
were
multi-dimensional, covering a
number of areas apart from medical experiences. Because of this I would like
to conclude by encouraging as many
other fellow students in other classes to
consider doing a foreign elective. For
more in formation contact Dr. J. S.
McKim .
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Straight Psychiatry
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Program, London, Ontario
Straight Medicine
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North York General Hospital
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Campbell, Donald Malcolm
Royal Victoria Hospital , Montreal, Quebec
Catania, Philip John James
The University of Western Ontario Integrated
Program, London, Ontario
Family Medicine
Celso, Renee Michele
Victoria Hospital, London, Ontario
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St. Joseph's Hospital , London , Ontario
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Victoria Hospital, London , Ontario
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Program, London, Ontario
Straight
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Victoria Hospital, London , Ontario
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Family Medicine
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Family Medicine
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Del Grande, Robert William
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Family Medicine
Fetherston, William Henry
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Francis, Thomas Patrick
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Family Medicine
Froese, Carol Ann
Sunnybrook Medical Centre, Toronto, Ontario
Straight Medicine
Garwood, John Lawrence
Victoria Hospital, London, Ontario
Gibb, Robert Alan
St. Joseph's Hospital, London, Ontario
Glazier, Richard Henry
Queen's University Integrated Program
Kingston, Ontario
Gleeson, Peter Francis
York Finch General Hospital
Downsview, Ontario
Gregory, David Arthur
Victoria Hospital , London, Ontario
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The University of Western Ontario Integrated
Program , London, Ontario
Straight Medicine
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Family Medicine
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Family Medicine
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Family Medicine
Kordish, Paul Louis
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Family Medicine
Koudys, Deborah Mary
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Family Medicine
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Straight Medicine
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St. Joseph's Hospital, London, Ontario
Leung, May-Chow Karen
St. Joseph's Hospital, London, Ontario
Love, Thomas Robert
Toronto East General and Orthopaedic Hospital
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McCall, Margaret Ann
Queen's University Integrated Program
Kingston, Ontario
Family Medicine
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Toronto East General and Orthopaedic Hospital
Toronto, Ontario
McGee, Donald Reginald
Metropolitan Hospital Centre
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Straight Surgery
McKelvie, Robert Samuel
The University of Western Ontario Integrated
Program, London, Ontario
Straight Medicine
Marchuk, Stephen Michael
Victoria Hospital, London, Ontario
Marr, Alison Jane
St. Joseph's Hospital, London, Ontario
Marsh , Alexander Stalker
St. Joseph's Hospital, London, Ontario
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Royal Jubilee Hospital , Victoria , B.C .
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University Hospital , London, Ontario
Mathies, David James
The University of Western Ontario Integrated
Program, London, Ontario
Family Medicine
Maxwell, James Henry
The Toronto Western Hospital , Toronto, Ontario
Medjesi, Alex
McMaster University Integrated Program
Hamilton , Ontario
Mixed
Middleton, William George
Scarborough General Hospital
Scarborough, Ontario
Moote, Carol Ann Stockall
The University of Western Ontario Integrated
Program , London, Ontario
Straight Medicine
Moote, David William
The University of Western Ontario Integrated
Program , London, Ontario
Straight Medicine
Mulloy , John Vickers
Scarborough General Hospital
Scarborough, Ontario
Musial, Alexander John
Montreal General Hospital, Montreal , Quebec
Neal, Donald Oliver
Scarborough General Hospital
Scarborough, Ontario
Nicholas , James Frederick
St. Joseph's Hospital , London, Ontario
Nicholls, Pamela Marie Anne
The University of Western Ontario Integrated
Program , London, Ontario
Straight Medicine
Osborn, David Douglas
Scarborough General Hospital
Scarborough, Ontario
Osmun, William Edward
Victoria Hospital , London, Ontario
Pace, Ronald Fredric
The University of Western Ontario Integrated
Program , London, Ontario
Straight Surgery
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Endorphins:
Neither Panacea nor Teapot Tempest
by C. W. Gowdey, M.D.
Just over three years ago a research
team in Scotland' discovered a new kind
of opioid substance which they called
"enkephalin" because it was found in
the head . These endogenous morphinelike substances, contracted to "endorphins", were quickly confi rmed by
investigators in Sweden, the U.S. and
England . The basic pharmacological
studies leading to the finding of endorphins and their receptors represent
important achievements in neuroscience
and may have a profound impact on
widely-differing areas of clinical practice. My review is an attempt to
describe some of the concepts and contributions in this rapidly boiling field of
research and also the potential for
significant advances in treatment.
-Goldstein 2 states that the discovery of
endogenous
opioids
followed
an
established tradition in pharmacology exemplified
by
the
discovery
that
acetylcholine is a neurotransmitter : first,
observation of the paralyzing effects of
the arrow poison curare; then st udies of
"receptive substance" in muscle and
ganglia stimulated by nerve stim ulation
or nicotine and blocked by curare;
studies of chemical structure related to
physiological activity; and finally the
demonstration of chemical transmission
and proof that acetyldtoline was the endogenous ligand of Claude Bernard's
"curare receptor"
in
muscle and
Langley 's "nicotine receptor" in ganglia.
Two prerequisites for discovery of
neurotransmitters are the conviction that
they exist and a suitable assay system
for measuring them so that they may be
puri tied and characterized.
Like many other pivotal concepts, the
idea that the brain might produce its
own opiates did not arise from one
brilliant flash of inspiration, but rather
was the result of combined beams of
light from widely divergent research
fields over several years. Receptor pharmacology,
sometimes
considered
a
relatively irrelevant game for academicians, played a vital role. The availability of sophisticated new apparatus and
techniques opened up further avenues
for research in the interactions between
and
biogenic
amines,
endocrines
behaviour. Although it had been known
for many years that the hypothalamus
and pituitary are involved in responses
of the organism to danger and stress,
Page 6

the multiplicity of actions of peptide
substances in the brain has only recentl y
been appreciated. In Holland , de Wied 3
has found that pituitary-derived peptides
have important effects on the acquisition
and maintenance of avoidance behaviour
in rats. Hi s results implied that ACTH,
MSH , etc . were deeply involved in learning. Other work~ showed that narcotic
analgesics can increase the secretion of
ACTH, growth hormone and that ovulation is prevented in some species.
Chronic administration of morphine inhibits the release of TSH, depresses the
pituitary-adrenal response to stress and
decreases gonadotropin and LH secretion .
Neurophysiological
experiments
that
ACTH,
MSH
and
showed
vasopressin can antagonize some of the
depressant effects of morphine on the
excitability of central neuwns 5 .
Another apparently unrelated area of
research which turned out to have great
importance in the endorphin story was
that of Li at Berkeley . During his investigations on the purification of
ACTH from sheep pituitary in 1964 he
found" a new hormone with some
lipolytic act1v1ty; he named it beta
lipotropin ( LPH) and determined that
it had a 91 amino-acid chain, but no
obvious function. Ten years later Li
isolated 7 a su bstance from hundreds of
camel pituitaries which a former student
of his had sent from Iraq; this compound was smaller than
LPH and,
like it, seemed to be a hormone without
a use. Within two years it was in great
demand and far more precious than
gold.
Other areas of research that led to
more illumination on the role and properties of endogenous analgesic substances
involved the mechanisms of pain relief.
The sites of action and the effects of
the natural and synthetic opioid drugs
continued to be investigated by many
groups, but although the results were
often interesting and sometimes led to
novel and exceedingly potent compounds, their direct influence on clinical
practice had been relatively minor. Martin and his colleagues 8 did demonstrate
stereo-specific and antagonist-reversible
polysynaptic blockade in the spinal cord,
but the complexity of the neural
mechanisms continued to plague investigators. The notion of a central pain
pathway was apparently conceived by

the Aristotelian school as long ago as
the fourth century B.C . and spinal
pathways had actually been studied by
Galen, but as recently as 1975 Akil
wrote 9 that the pain pathways into the
brain are not well understood beyond
the level of the thalamus . Their terminations in the cerebral cortex are
unknown, and their interactions with
limbic structures remain obscure. Even
the mechanisms involved in the simplest
withdrawal reflex at the spinal cord
level are complex. Even with all the recent research activity her statements are
still true today .
For many years neurosurgeons have
recognized the fundamental importance
of inhibitory processes in the function
of the nervous system and have reported
varying success in pain relief from
stimulation of peripheral nerves or after
central stereotactic operations . Some of
these procedures were based upon the
gate control theory of Melzack and
Wall' 0 which emphasized interactions
among different types of sensory input
because of observations that non-painful
stimuli could inhibit pain . Within the
past few years Mayer , Liebeskind and
Akil" 13 have accumulated evidence of
a central pain suppressive system including the mesencephalic central gray
and peri ventricular gray matter, electrical stimulation of which leads to
analgesia in experimental animals and
relief of chronic pain in some patients.
The analgesia can be blocked by naloxone'4 16 and cross-tolerance to morphine
occurs. This observation represents an
important focusing of light on the problem of pain. The role of the pituitary in
pain control is still not understood, but
the remarkable report of Moricca 18 in
which "pain relief was complete, immediate and long-lasting " in 605 of 687
patients
with
advanced
malignancy
treated by chemical hypophysectomy
begs for explanation.
In the early 1960's Kosterlitz and his
colleagues at Aberdeen began a series of
studies of the peripheral effects of
opi~tes with an ingenious preparation
dev1sed by Paton which involved electrical stim ulation of isolated strips of
guinea pig ileum or mouse vas deferens.
!h~y. found that morphine derivatives
1~1b1ted the neurally-mediated contractions of these tissues; the inhibition involved specific receptor sites; it was

blocked by the specific narcotic antagonist naloxone, and somewhat surprisingly, the ability to prevent contractions in these isolated smooth muscle
preparations was parallel to the potency
of these narcotics as analgesics 17 •
In 1976 Goldstein first demonstrated 1 8
the existence of stereospecific opiate
receptors in mouse brain fractions using
radio-isotope labelling techniques. This
finding that opiates act on brain cells by
combining in a highly selective manner
with particular protein molecules on
of
great
their
membranes
was
significance not only intrinsically, but
also because it led to the question: since
opiates are not a normal body constituent, why does the brain possess receptors for them? The question became
even more pertinent after further work
with powerful, radioactive narcotic
agonists and antagonists by Snyder's
group at John Hopkins' 9 20 , Simon's at
New York University 21 and Terenius's at
Uppsala 22 soon confirmed that indeed
specialized opiate receptors did exist on
the membranes of nerve cells in the
brain and spinal cord in many
vertebrate species. The affinity of morphine and other opiate drugs for these
receptors seemed to parallel closely their
pharmacological potency as analgesics 23 ,
leading to the conclusion that somehow
analgesic potency of opiate drugs could
be correlated with their ability to bind
specifically to opiate receptors in either
ileum 24 or brain 21 •
Where are these opiate receptors
Using
auto-radiographic
localized?
techniques groups of investigators in the
U.S. 19 21 25 and Sweden 22 mapped out
the differential distribution within the
central nervous system and found
similar regional variations in the density
of receptors in several mammalian
species. Pert found that opiate receptors
existed in creatures as far down the
developmental ladder as the hagfish 28 ,
which is thought to have been in the
seas for some 350 million years, a fact
that made it highly improbable that a
special
nerve
pathway
had
been
developed to interact only with an extract of oriental poppy. That receptors
occur in all vertebrates but not in
subvertebrate species suggests that both
the receptors and the endorphins are advanced evolutionary adaptations with
important survival value 2 •
The pattern of distribution of receptors is strongly correlated with areas of
the nervous system known to be involved in the perception and processing of
pain. According to Goldstein 27 , the
clearest example of a mechanism involving these receptors is in the spinal cord,
the first relay in the pain pathway. The
dorsal root ganglion cell is a bipolar
neuron, sending a long axon out to the
periphery, the terminal of which acts as
primary pain receptor. The other axon
enters the dorsal horn of the spinal cord
where it synapses in the substantia

gelatinosa - a region rich in opiate
receptors (and in enkephalin). There is
evidence now that another peptide,
substance P, is the transmitter of the
primary afferent neuron. It is believed
that short interneurons working through
enkephalins modulate the output of
substance P and thus are capable of
suppressing noxious inputs at the
primary relay . Downflowing pathways
originating in the periaqueductal gray
and other brain stem structures activate
these neurons, presumably through the
neurotransmitter serotonin 28 • In this way
stimulation in the brain stem would act
through
these pathways to cause
enkephalin release and inhibition of pain
in the spinal cord. It is obvious from
inspection of the tables 21 showing the
regional distribution of these receptors
in monkey and human brains that by
far the highest concentration is in components of the limbic system or regions
associated with it: amygdala , septal
nuclei, peri ventricular gray matter , hippocampus, centromedian and dorsomedian nuclei of thalamus , preoptic and
supraoptic nuclei, temporal lobe, etc .
This system is obviously involved in
poorly-localized
and
emotionallyinfluenced pain .
Elsewhere in the brain stem, opiate
receptors are found in nuclei associated
with afferents not carrying pain 25 , a
fact that may explain such effects of
morphine as suppression of cough, or-

thostatic hypotension 29 , reduction of
gastric secretion, libido and urinary output and the nausea and vomiting due to
of
the
medullary
stimulation
chemoreceptor trigger zone 30 •
Meanwhile, microinjection techniques
in animals revealed that the most important sites for the anti-nociceptive effect
of morphine are in the periventricularperiaqueductal gray matter extending
from the lower portion of the third ventricle along the aqueduct into the fourth
ventricle. More lateral and less sensitive
was an area ranging from the substantia
nigra through the red nucleus up to the
intralaminar region of the thalamus 31 •
Pert pointed out 32 the strong positive
correlation in the brain between those
sites most effective for morphineinduced analgesia and the areas rich in
opiate receptors.
With all these results accumulating it
is not suprising that a race developed
among neuroscientists to discover the
endogenous opiate. Hughes described 33 a
crude extract from 300 g of pig brain
which, when tested on the isolated
mouse vas deferens preparation, gave
evidence of opiate activity . At the same
meeting Terenius announced the properties of an endogenous ligand that had
been isolated in his laboratory in 1974 3 •
from acid-water extracts of rat or calf
brain homogenates using a binding-assay
procedure.
First prize went to the Hughes and
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Kosterlitz team; they reported' in Nature
in late 1975 the isolation and structures
of the first two endogenous opiates,
from pig brain, and called them
and
leucinemethionine-enkephalin
enkephalin. Both were pentapeptides
and, like morphine, could be bioassayed
because
they
inhibited
electricallyinduced contractions of the vas deferens .
The authors noted that a replica of
methionine-enkephalin could be found in
the chain of 91 amino acids which make
up Li's giant (3- lipotropin. This report of
the exact structure of the enkephalins
caused a veritable explosion of activity.
In the meantime, Smyth's group 35 at
the National Institute for Medical
Research in Britain had isolated and
identified
constituent
fragments
of
lipotropin from the pituitary. Not only
did the long-recognized (3- MSH occur as
an intact peptide, but so could their "Cfragment"(i.e. (:J· LPH-(61-91)). Realising
from a discussion with Hughes that the
structure of met-enkephalin had the
same sequence as that at the N-terminus
of their "C-fragment", they postulated
that the latter might be the precursor of
met-enkephalin.
Injection
of
this
material into the third ventricle of the
cat induced marked analgesia (with a
potency about 100 times that of morphine). The hectic pace of this fastmoving research may be appreciated
from the report 36 that on the west coast
of California Goldstein read the aminoacid sequence as reported in the
Hughes' paper to Li over the telephone .
Li realized that the molecule was identical with that terminal part of his 30amino acid "useless" camel pituitary
hormone. It was soon found to have
powerful analgesic activity 37 • This compound later turned out to be identical
with beta-endorphin. Goldstein's group
reported the presence of an endorphin in
available
ACTH
a
commercially
extract 36 and in bovine and rat pituitary
glands 39 • Guillemin and his colleagues
also isolated endorphins with morphinomimetic
actlVlty
from
hypothalamus-neurohypophysial extracts
and established their structures•0. Four
endorphins were recognized, all containing met-enkephalin and all present in
(3-lipotropin: a -endorphin is (3 -LPH
(61-76); (3 -endorphin is (61-91); Y endorphin is (61-77) and ll is (16-87).
Though they differ structurally by only
one amino acid, alpha and gammaendorphin have opposite effects: c~ endorphin produced short-term analgesia
and tranquilization not unlike that after
large doses of enkephalin, but Y endorphin made animals violent, irritable, and apparently hypersensitive to
pain 4'. It thus seems that the same
'prohormone' can give rise to agonist
peptides
(e.g.
met-enkephalin, (3- endorphin) and antagonists (e.g. MSH
and Y -endorphin). The ongm of
leucine-enkephalin is till a mystery; it is
present in amounts only 25-300Jo of metPageS

enkephalin in pig, rabbit, guinea-pig,
mouse and rat brains, but its precursor
is unknown 42 .
The distribution of the enkephalins in
the brain was studied by Kosterlitz's
group 42 by mouse vas deferens method
of bioassay and by Snyder and his colleagues by immunohistochemical techniques43 . As expected, they found that
regional variations in tissue levels of
enkephalins in the brain appeared to
parallel the relative density Pert had
reported of the opiate receptors.
Enkephalins are localized in nerve terminals and axons of systems that
subserve integration of sensory information, including pain. Both groups found
that the two enkephalins are present in
various parts of the brain, but in different proportions. Endorphins have also
been isolated from brain tissue, but they
are less widely distributed than are the
enkephalins and are in much smaller
concentrations than in pituitary where
they are concentrated in the pars intermedia•• . Pituitary (3 -endorphin is
probably not the source of brain endorphin because hypophysectomy does
not modify brain levels 45 ; pituitary contains little if any enkephalins••.
(3 -endorphin and ACTH are consi dered originally to be part of a 31000
dalton
precursor
glycoprotein 47 .
Guillemin and Bloom demonstrated 48 an
equimolar secretion of endorphins and
ACTH in several conditions (severe
stress, addition of corticotropin-releasing
factor to adenohypophysial cell cultures,
cells
from
human
ACTH-secreting
tumors.) In vivo these secretions were
antagonized by hypophysectomy or administration of glucocorticoids. These
authors suggest that the response of an
organism to stress involves immediate
secretion of pituitary hormones; some,
like ACTH and growth hormone are
concerned with somatotropic (metabolic)
adaptive reactions, whereas other , like
(3 -endorphin and (3 -MSH, are related
to neurotropic or psychotropic adaptive
reactions.
Enkephalins are also present in the
noradrenergic cells of the adrenal
medulla and in autonomic ganglia, but
their function is not known 49 . Those
found in the guinea-pig ileum may be
involved
in
regulating
intestinal
motility 60 . Endorphin activity can be
generated from (3 -LPH, which itself is
devoid of opioid activity, by incubation
with
guinea-pig
ileum
or
brain
homogenates"'.
But
while
it
is
postulated that met-enkephalin synthesis
might proceed through (3 -LPH as
precursor, there is no experimental
evidence for this.
Holaday
et
a/ 62
found
that
hypophysectomized rats are supersensitive to the hypothermic effects of morphine and (3 -endorphin. Guillemin 41
reported that whereas (3 -endorphin
lowers body temperature, Y -endorphin
raises it - an effect similar to that

after met-enkephalin 53 . Similar responses
have recently been studied in our
laboratory by Thornhill after most doses
of heroin 5 4 and morphine••, and by
Tepperman 56 after met-enkephalin, but
there is a delay in onset. Thornhill et
a/ 57 also showed that repeated administration of morphine or heroin led
to pronounced feeding at the wrong
time in the diurnal cycle. Brands et a/ 68
later found that naloxone reduced the
food intake of rats whether they had
been fasted or were feeding spontaneously. (3 -endorphin induces extreme
immobility and muscular rigidity 68 and
intracisternal injections, like morphine,
can cause marked respiratory depression,
temporarily reversed by naloxone 60 .
In 1976 Akil et a!"' reported that
acute stress induced by intermittent footshock produced an anti-nociceptive effect and a significant increase in endogenous opiates in rats. With chronic
stress opiate levels returned to control
values. Arnir and Arnit 62 of Concordia
University
showed
that
single or
repeated daily sessions of immobilization
stress in rats changed pain-related
behaviour and they suggested that the
endogenous system involved may be
mediating the affective but not the sensory factors of pain-related responses.
These results are in accord with current
pharmacological teaching re narcotic
analgesics:
in
clinical
doses pain
tolerance is increased far more than
pain thresholds.
Gent and Wolstencroft 28 applied morphine, met-enkephalin and endorphin by
iontophoresis to single neurons in the
brainstem of cats. Neurons in the
reticular formation of the medulla and
pons and in the raphe nucleus were inhibited or unaffected by all three. In the
midbrain many neurons were inhibited
but some, particularly in the periaqueductal gray, were excited by morphine and endorphin, excitation by metenkephalin
being
less
frequent.
Substance P causes excitations of single
units in the cat spinal dorsal horn; morphine causes depression 5 3.
Andersen et at•• found that iontophoretic application of met-enkephalin
reduced the spontaneous firing frequency
of nociceptive neurons in the trigeminal
nucleus
of decerebrate
cats. The
response evoked by stimulation of the
tooth pulp was inhibited by enkephalin,
an effect blocked by iontophoreticallyapplied naloxone. Nociceptive neurons
were strongly excited by substance P. In
1975 Mayer had pointed out 86 the
simi larities between stimulation-evoked
and morphine-induced analgesia: both
are thought to involve an active process
of pain inhibition rather than merely
blockade of pain input· both can be
modified by biogenic a~ines, both are
blocked by naloxone and both are subject to tolerance. Chapman reported ..
that . trans-cutaneous electrical stimulation mduced analgesia during tooth pulp

stimulation in the majority, but not in
all subjects; the effect was blocked by
Pomeranz 87
at
Toronto,
naloxone.
Seguin 88 at Western Ontario and others
have reported similar analgesic effects
with electro-acupuncture in animals, but
others disagree 5 8 • Pomeranz claims 70 this
analgesia is blocked by hypophysectomy,
which suggests that acupuncture causes
release of endorphins from the pituitary.
Modern Chinese methods for inducing
acupuncture analgesia often involve lowfrequency electrical stimulation of the
inserted needles. Studies in occidental
countries have confirmed that pain
thresholds and pain tolerance in some
subjects are increased by this procedure.
As early as 1973 Chang had claimed 7 '
that morphine and electro-acupuncture
analgesia led to a decrease in the rate of
repetitive discharge of cells in the medial
hypothalamus. Korf et af1 2 showed that
cells in the locus coeruleus increased
their firing rate when noxious stimuli
were presented; morphine blocked this
increase and naloxone blocked the effect
1975
Mayer
of
morphine.
In
postulated 85 that acupuncture may act
"morphine-like"
by
releasing
a
substance which, by a presynaptic effect,
activates
a
pain-inhibitory
system.
Naloxone would be expected to reverse
this analgesic effect and Mayer reported
preliminary results to support this conjecture. Sjolund and Eriksson 73 confirmed the blocking action of naloxone in
electro-acupuncture analgesia and in
1977 they showed 74 that levels of endorphins increased in the cerebrospinal
fluid of patients relieved of pain by this
method. It is of some interest that
nalaxone does not block analgesia caused by hypnosis nor general anaesthesia
with halothane or nitrous oxide.
In a study of pain thresholds
measured by electrical stimulation of
tooth pulp, volunteers received acupuncture, no treatment, or placebo (i.v.
saline and told it was a powerful
analgesic)1 5 • Of the 20 subjects showing
elevations in threshold by acupuncture
II were given naloxone, i. v., and within
five minutes their thresholds were in the
control range. The other 9 were injected
with saline and their levels remained
high. Levine et af7 8 studied pain by two
rating scales after extraction of impacted
third molars in a randomized, doubleblind trial. Patients were told they might
receive morphine, placebo or naloxone
injections at two hours and three hours
after the start of anaesthesia (diazepam,
local mepivacain and nitrous oxide.) In
patients receiving placebo as the first injection and naloxone or placebo one
hour later the mean pain level increased
during the hour after the first injection
and increased even more when naloxone
was given as the second injection. This
implies that the surgical procedure led
to release of endogenous opioids.
Analysis showed that naloxone enhanced
the pain ratings much more in placebo

responders but had no obvious effect on
placebo nonresponders. Morphine itself
is known to be more effective in
placebo reactors than in non reactors 77 •
Can placebo reactors turn on their endorphin system? Perhaps the time has
come to envy the placebo reactor rather
than dismiss him as neurotic .
Studies of tolerance with these
substances are few because of their scarcity and cost, but tolerance does develop
to f3 -endorphin and met-enkephalin, as
it does to morphine on repeated injections and there is cross tolerance between these substances 46 • Prolonged administration followed by naloxone induced a tyPical "morphine-abstinence" syndrome. f3 -endorphin is more potent that
morphine in suppressing signs of morphine abstinence 78 . Animals will selfadminister enkephalins as they do morphine and it is suggested that leuenkephalin may play a special role in
the primary reward pathways involving
the
locus
coeruleur ,
mesencephalic
and
lateral
reticular
formation
hypothalamus - the same pathways in
which electrical self-stimulation is maintained by several species, including
man 2 •

It is possible that enkephalins and/ or
f3 -endorphin are involved in the
development of narcotic dependence. Is
the drug hunger of the heroin addict
due to endorphin deficiency? Does administration of exogenous narcotic drugs
decrease endogenous opioid synthesis so
that the central nervous system becomes
dependent upon the exogeneous source
and when its administration is stopped,
withdrawal effects occur because of deficiency of endogenous opiates? Another
hypothesis, proposed by Goldstein 2 , is
that a genetic deficiency of endorphin
production might predispose to opiate
addiction. Such an idea suggests a new
way of looking at narcotic addiction; if
it were a "metabolic disease", then
society's harsh attitudes might be even
more inappropriate. Evidence for these
hypotheses is not yet available.
Enkephalins and endorphins seem to
require an intact N-terminal tyrosine to
combine with the opiate receptor and
exert their biological effece 9 • In 1978 a
specific
high-affinity
enkephalindegrading peptidase localized to brain
membranes was found whose concentration varied in the brain according to the
enkephalin levels, its concentration in-
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creasing with chronic morphine treatment80. Widespread distribution of peptidases probably accounts for the very
short biological half-life of enkephalin,
which is measured in minutes. Synthetic
analogues of enkephalins which resist
enzymatic destruction are under investigation8'.
As early as 1977 Terenius' group
mentioned 82 the potential role of endogenous opioids in regulation of pain
perception and in 1978 Hosobuchi and
Li announced 83 relief of intractable pain
in three patients by the intraventricular
injection of 300 microgm human (3 - endorphin. Relief of chronic pain in each
patient preceded any significant alternation in acute pain threshold . Both were
blocked by naloxone. With a larger dose
relief was profound and lasted about 8
hr ., but there was no alteration in vital
signs, neurological function or behaviour
except that the patients appeared more
relaxed and cheerful. Last August, Akil
et a/ showed 84 that the analgesia evoked
by electrical stimulation of periventricular brain sites in 8 patients was accompanied by a significant increase in
enkephalin-like material in the ventricular cerebrospinal fluid . Moreover,
they, like Terenius 86 , found that the
baseline levels of enkephalins in patients
with chronic pain were lower than those
in normal subjects.
Terenius's group reported that the endorphin levels were very low while patients were suffering chronic pain; does
this mean a hypoactive "endorphin
system" or high consumption of released endorphins? They also found 85 in patients classed as having mainly chronic
organic pain syndromes that the lumbar
CSF showed significantly lower endorphin activity than that of patients
whose pain was consid~ed pyschogenic.
There was a significant correlation between CSF endorphin levels and depth of
psychic depression as reported by the
patients, but no correlation with anxiety
or motor retardation . In depressed patients endorphins may be I 0 times
than
in
normal
subjects 88 .
higher
Terenius' results indicate the importance
of other actions of the opiates aside
from pure analgesia in alleviating pain:
patients feel better than can be attributed simply to their relief from pain.
It is conceivable that exogenous opiates
turn off endorphin production and thus
reduce depression evoked by high levels .
In a recent study87 of two patients in
Paris with congenital insensitivity to
pain but no other neurological deficit,
the thresholds for a nociceptive flexion
reflex were markedly elevated, but they
were greatly reduced within 10 minutes
after an injection of naloxone .
One great help in studying the role of
opiate peptides and receptors is the
Pa e 10

availability of highly specific antagonists
like naloxone and naltrexone, but it was
difficult to assign a very significant role
for endogenous opiate peptides when
there had been widespread recognition
that sudden blockade of the receptors by
i.v. naloxone had no appreciable effect
on the organism. Some observations,
however , suggest that naloxone causes
hyperalgesia 88 and lowers pain tolerance
in animals 8 ' , the implication being that
endogenous opiate peptides may normally set these thresholds . All of this suggests that an endogenous pain-inhibiting
system can be called into action whose
effects can out-last the duration of
stimulation by many hours. It is not all
that simple: Akil et a/ 81 found that
naloxone only partially blocks the
analgesic effects of electrical stimulation
and tolerance does not always occur .
Non-opiate mechanisms must also exist.
In 1978 Feldberg and Wei reported 88
that
injections
of
morphine, f3 endorphin and leu-enkephalin caused an
increase in heart rate and blood pressure
when injected into the cerebral ventricles, but opposite effects when inintracisternally .
The
carjected
diovascular system is considered to be
very sensitive to the effects of both exogenous and endogenous opiates and a
recent study on shock is related to this
hypotensive action of opioids 90 . Rats injected with E. Coli endotoxin had a
precipitous fall in blood pressure and
when it had reached 65 mm hg, an injection of saline or naloxone was given .
Naloxone not only rapidly reversed the
hypotension, but when given prophylactically , prevented it. This experiment
may be of great significance not only
because it suggests that endorphins may
be involved in the fall of arterial
pressure in shock, but it also implies
that narcotic antagonists may have
therapeutic value in that state. Through
feedback control it may even provide a
rationale for the use of corticosteroids.
Akil reported at the latest meeting of
the Society for Neuroscience a finding
with fascinating implications: endorphin
levels increase markedly in the blood of
pregnant women . Is this an aid to
painless natural childbirth? Is it a means
of keeping a foetus quiet, content and
not breathing?
Effects of the opiate peptides and
their antagonists on the mind are less
clear than on the brain, but confusion
does not make them less intriguing.
When it was discovered that intraventricular (3 -endorphin induced marked
catatonia in rats and mania and
hallucinatory behaviour in cats, as
opiates are known to do, it was considered that the peptides might be in-

volved in affective disorders. In 1977
two psychiatrists Kline and Lehmann
obtained some of Li's precious newlysynthesized f3 -endorphin and injected it
into 15 psychiatric patients 38 . They
claimed antipsychotic, antidepressant and
antianxiety effects 9', but the experiment
was badly-designed, not double blind,
and the material was even given to some
patients still taking antipsychotic drugs;
such was the haste to be first. At best,
their results are equivocal. Terenius
reported increased endorphins in the
CSF of acutely disturbed schizophrenic
and manic patients and the levels
decreased during remiSSIOn of the
psychosis 88 • The Swedish investigators;
reasoning that if endorphin levels do
correlate with the severity of the
psychosis, then naloxone should be
beneficial, found 82 that it blocked
auditory
hallucinations in
paranoid
schizophrenics. Others disagreed with
these results, but in a good double-blind
crossover
study 83
naloxone blocked
hallucinations, decreased anxiety and improved mood. Others showed a decrease
in euphoria scores, especially in manic
patients. The implications are that endogenous opiates are involved in some
psychotic
symptomatology;
certainly
these peptides are strategically located
for modulating events in limbic struc·
tures .
Goldstein writes 2 that whatever roles
endorphins have, their interplay with
nervous and hormonal effects in the
regulation of behaviour represents the
perfection of millions of years of evolu·
tionary adaptation. To swamp endorphin
receptors everywhere in the body with
repeated high concentrations of exogenous opiates such as heroin can only
upset the natural systems and suggests
even greater caution in prolonged use of
antagonists and the non-medical use of
narcotic analgesics.
The very existence in the body of peptides with opiate activity raises the question of their true physiological role
because it seems that all mammals have
them . It is everi possible that their
opiate-like activity is misleading us 48 •
Results of the studies I have summarized are very new, very exciting, creative,
and full of ·promise, but although all
kinds of wonderful and ingenious suggestions are being made in the literature
about novel neurotransmission, blocking
acute pain, suppressing and modulating
chronic pain, involvement in stress and
shoe)<, reversing schizophrenic symp·
toms, relieving psychic depression and
anxiety,
explaining
drug
addiction,
acupuncture and placebo responses, the
real ex~erts like Kosterlitz, Hughes and
Goldstem warn us 84 that we still cannot
assign a role to the enkephalins. We do
~ot even know for sure what target
tissues they act upon and it is not yet
proper . to talk about an endorphinergic
anal~esJc system which mobilizes opiate
peptldes to cure our ills.
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Antibiotic Update
by Dr. E. D. Ralph
Over the past five years, several new antimicrobial agents ha ve been introduced. In
this article, I will brieny review what I consider is their role in the therapeuti cs of in fectiou s di seases by co mparin g them with
older, established antibiotics. Only significant differences or similarities will be emphasized and no detailed pharmaco logic o r
mi crobiologi c re view of these dru gs will be
attempted .
Penicillins

Two relatively new penicillin ana logue
are currently available. The first, amoxicillin (AmoxiJR, PenamoxR, NovamoxinR,
Polymo xR, AmoxicanR), is n ow we ll
established and has superceded o ral ampicillin to a large extent. Its spectru m of activity is vi rtually identical to that of ampicillin but it po ssesses marked pharmacokinetic advantages includin g better
absorption (even in the prese nce of food)
and higher blood a nd urine levels. As a
result of this, the indi vi dual doses of amoxicillin required are only 500Jo those of ampicillin and the drug ma y be given every
eight rather than every six hours. There appears to be co ncomitantl y less diarrhea, a
common si de effect of ampicillin,
associated with its use also . However, eve n
with the dose reduction, the drug is still
so mewhat more expensive than oral am picillin and this must be weighed against its
obvious advantages. At the present time,
moreover , ampicillin is the only drug
available for parenteral (intramuscular or
intravenous) use.
Ticarcillin (TicarR) is the newest penicillin
analogue with an antibacterial spectrum
and pharmacokinetics very s imilar to that
of carbenicillin. It is available only in a
parenteral form and is therefore rest ri cted
to hospital use only. It is more active
against mo s t s train s of Pseudomonas
aeruginosa than carbenicillin and therefore
the daily dose required in pse udomonas infections is approximately 600Jo that of
carbenicillin (for example, 18G vs . JOG).
This results in a substantially lower sodium
load for patients on ti ca rcillin (approximately 90 milliequivalents vs. 150 milli equivalents of so dium per day with
carbenicillin) and may also cause less
platelet dysfunction and bleeding problems
which large doses of carbenicillin have been
shown to produce . Despite the lower dose,
however, there appears to be no significant
cost advantage in using ticarcillin rather
than carbenicillin, at the present time .

For se ri o u s sys temic Pseudomonas
aeruginosa infections, eit he r ti ca rci llin or

infections and a different one for Gram
negative infections .

ca rbe nicillin is ge nera ll y used in co mbinati on with ge nt a mi ci n o r tobramycin since a n
ami nog lycoside combin ed with these dru gs
usually produces a sy nergi stic antibac terial
effe c t. Ticarcillin o r ca rb eni cillin alone ma y
also be used in th e treatment of infection s
caused by ot her G ram negative o rga ni sms
resis tant to a mpi ci llin , o r in patients in
whom an aminog lycos ide an tibi otic is co ntraindicated .

Aminoglycosides

Cephalosporins

The cep ha losporins a re excell ent a lternative bactericidal drug for patient s
a ll ergic to the penicillins (cross h ype rse nsitivity between these tw o classes of dru gs
being on ly 5 to IO OJo). Their a ntibacter ial
spectrum is rather broad a nd includes all
staphylococc i (including penicillin resista nt
s trains) and seve ral Gram negative
organis ms including klebsiella. One signifi can t drawback is th e ir inabi lit y to cross th e
blood brain barrier in therapeutic concentrations and therefore they s hould not be
used in the tre atment of meningiti s.
The most recent cephalosporin preparation introduced is cefamandole (Mandol R)
which differs from th e older drugs suc h as
cep halothin (KeninR) in having a broader
Gram negative pectrum. Another which
will be intro du ced sho rtl y is cefox itin (actu a ll y a cep ha m ycin derivative) which is
also active agai n s t many s train s of
Bacteroides jragilis, a n int es tin a l anae robe
which is ge nera ll y resistant to the o lder
cephalosporins.
Cefazolin (Ancef R, KefzoJ R), whic h has
bee n available for approximately five years,
is sti ll distinctive among the cephalosporins
in possessing very favo ur able pharmacoki netic properties with high serum
levels and a long half-life. This results in a
lower dail y dose (I G give n every 8 hours
I.M . or I.V ., for most patients) than the
other cephalosporins cur rently avai lable
and has become the cephalosporin recommended at our hos pital. Since cefazolin is
not available as an oral preparation, either
cep hale xin (KeflexR, CeporexR) or
cep hradine (VelocefR) can be used .
Even with the availability of newer
cephalosporins, cefazolin will like ly remain
the drug of c hoi ce in most situations.
However, for specific se rious infections
s uch as endocarditis, it may be better to
refine our therap y with the cepha lospori ns,
choosing a particular one for Gram positive

Tobramycin (NebcinR) and amikacin
(AmikinR) are the most recently introduced
aminoglycoside drugs. Tobramycin is very
similar to gentamicin in its spectrum of activit y against Gram negative organisms, except that it is more active against st rains of
Pseudomonas aeruginosa but less active
against ce rtain less common Gram negative
organisms s uc h as serratia . It appears to be
less nephro- and ototoxic than gentamicin
in animal models but no convincing
evidence has been prese nted that it is
significantly less toxic in the human . Both
ge nt a mi cin and tobramycin are prescribed
similarl y with modifications for impaired
renal function and therefore the BUN and
serum creat inine are followed closely while
patients are on these drugs. If there is any
co nce rn abo ut ototoxicity, audiometry can
be performed periodically since the loss of
high-tone frequency perception may
precede obvious vestib ul a r or auditory toxicity . Peak a nd trough se rum levels of the
drugs are also frequently measured as well
to ensure therapeutic but not toxic levels
since th e therapeutic index in these drugs is
quite low. Either gentamicin or tobramycin
is used curre ntl y as the aminoglycoside of
c hoi ce in most hospitals.
Amikacin, the newest a minogl ycos ide
available, is closely related to kanamycin,
an an tibiotic whi c h was su perceded to a
large extent by gentamicin in the late
1960's. Amikacin has a spectru m of activity
similar to gen tami cin and tobramycin except that it is often active against organisms
which are resistant to these drugs. The dose
and do s age interval are simi lar to
kanamycin with modifications made for impaired renal function . Amikacin is an excellent drug to have in reserve for gentamicin or tobramycin resistant strains, but
its use fulness in this respect may be curtailed if it is used as a first-line drug.
Trimethoprim-sulfamethoxazole

(cotrimoxazole)
Trimethoprim-sulfamethoxazole (SeptraR, BactrimR) represents the product of
basic pharmacologic research to develop a
sy nergistic combination of two antimicrobials. Whereas sulfonamides have
been available for many years, their spectrum and antibacterial effects have been
enhanced greatly with the addition of
trimethoprim. The fixed combination of
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these two antimicrobials has a broad spectrum of activity against both Gram positive
and negative organisms (except Pseudomas
aeruginosa) and has been used primarily in
the treatment of upper a nd lower
respiratory tract and urinary tract infections. It may be especially useful in recurrent or relapsing infections caused by resistant Gram negati ve o rgani sms . Unfortunately, it is likely that some of the older
antibiotics have been neglected wit hout
good cause as a result of the widespread use
of cotrimoxazole. In ge neral , cotrimoxazole
should be considered in most infections as a
second-line dru g after such established antibiotics as the penicillins, cephalosporins,
sul fo namides alone , erythromycin or

tetracycline . For example, tn uncomplicated urinary tract infections, t he
penicillins or sulfonamides are usually just
as effective as cotrimoxazole and are often
cheaper.
Specific indications for trimethoprimsulfamethoxazole are rather limited and inc lud e
c hr o ni c
prostatitiS
(since
trimethoprim alone penetrates very well into prostatic tissue) a nd the prophylaxis of
recurrent urinar y tract infections in
fema les . In most other infections, however ,
other antibiotics are just as effective and
have the advantage of being available in a
parenteral form . Its rol e in antimicrobial
chemotherapy , therefore, appears to have

been exaggerated and shou ld be more
precisely defined .
In the foreseeable future, most of the
newer antibiotics m arkete d will be
cephalosporins, likely differing mainly in
their spectrum of activity. They may provide les s toxic alternatives to the
aminoglycosides in the treatment of the
more resistant Gram negative infections .
When contemplating the use of any new
drug , it is important to stress that many of
the older antibiotics have survived the test
of time with respect to serious side effects
and that only with increased clinical experience will some of the rarer side effects
of the newer antibiotics be recognized.
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On the Competitive Urge

by Doug Zochodne
To have the urge might be said to imply potential or hopeful utilization of
energy. In the case of the archetypal
medical cadre, normal libidinous drives
are sublimated into pathological competitive drives . In other words , being on
top of your classmate refers to academic
superiority rather than reproductive
alignment.
The medical student has rested his
self-esteem in pre-med years on the
ability to thrash to an intellectual pulp
his pre-med rivals . Once the cycle of being better is begun and reinforced, the
student is incurable. However, both
nature and marks in medical school
have devious ways.
Med students employ a variety of
ways to deal with this urge . It 's not
quite as simple as a cold shower
however. Like ego defense mechanisms
in psychiatry, these urges can be dealt
with in more advanced and complicated
ways or by more primitive and simple
ways . Probably the most primitive way
you can deal with your " urge "
(competitive) is by doing that much
more study and work than your peers in
order to appear intellectually superior.
Surgeons are known to work hard . The
only explanation here, I gather , is that
this way of dealing with your "urge"
doesn't work so well . Another primitive
way of handling the "competitive urge"
is by using denial. Eg: a pre-exam conversation between students,
"I didn't study at all for this exam."
"I studied even less!"
"Impossible, I went to the movies
last night."
"That's nothing! I played gin rummy
all night and drank beer .''
"So I lost all my ICC notes, Harrison's, Merck Manual and Guyton
on the horse races last night."
"That's nothing! I never took notes,
bought the textbooks, or attended
lectures."
etc., etc., etc.,
A more advanced means of coping
with competitive urge is by asking professors seemingly extremely difficult
questions during lecture periods. This
idea here is basically,
"Wow, that guy must ktt0~ a lot if
he's asking questions about this stuff.
Some examples of questions to ask that

will make you appear bright:
"What percentage of people with
loose teeth have Burkitt's lymphoma
of the jaw?"
The person who asked this question
subsequently had radiographs of his
mandible taken when his classmates
knocked his teeth out for asking such a
stupid question.
Or:
" What is the incidence of mice, who
have had their foot pads injected
with measles antibody, who have an
IQ of greater than 50?"
Just as a child becomes an adult , a
medical student becomes a physician. In
fact an old saying explains this rather
well, "A med student is simply a doctor
with his brains kicked out." Anyway, a

physician, like a student, retains his
competitive urge .
If he is a professor , his underlings
must be able to deal with this. How to
handle it? Always appear to be working
harder for solutions than the professor
but appear much more stupid despite
this work . If the professor blunders,
take full responsibility (this may not be
optional). Ask questions for which the
professor should know the answer to.
This may backfire if the professor is
unusually limited .
In summary , the medical student must
really learn to be like the student council candidate who demanded , "Better
food , more booze , more broads!" instead of "More Harrison's, more ICC,
more exams!"
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Contraception:
The Past, The Present, The Future
by A. Albert Yuzpe, MD.

The past two decades have witnessed
the greatest changes in the field of conception control, not only from the
standpoint of increased numbers of
available contraceptive products , but
more important in the attitudes of both
the medical and lay public to the basic
concept of "man's right to adequately
space and limit the number of his progeny, i.e., family planning".
The following is a brief review of the
history of contraception which has
brought us to our current "state of the
art". Consideration of future possibilities in conception control are also
presented . This presentation is not
meant, by any means, to be a comprehensive in-depth review, but rather to
present the highlights of the past, present and future of contraception.
THE PAST
Contraception is not a new concept.
Dating back to ancient times, women
have attempted to prevent conception by
various methods, some of which seem
rather strange or bizarre in the light of
our current knowledge of the reproductive process. Still, these • attempts were
often the only means available.
Incantations, physical gyrations and
the insertion of various potions into the
vagina (many of which were extremely
noxious to tissues and resulted in permanent scarring and stenosis) were
employed .
The condom, originally produced as a
membrane from animal intestines, was
developed as a means of protection
against venereal disease , a problem
which has plagued man throughout centuries . Its artifertility effect was a bonus
to the consumer .
During the pre-Christian era, caravan
leaders were known to place pebbles into the uteri of their camels in order to
prevent them from becoming pregnant
during their long travels across the
desert.
It was not until the elucidation of the
steps in the reproductive process of both
the male and the female, that contraceptive technique£ were developed which
would act at one or several sites along
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the complex pathway from conception
to implantation.
THE PRESENT
I. Pseudo-Contraceptive Techniques
Coitus interruptus, or withdrawal and
douching may have played a role in
contraception when few better techniques
were available, but in this age has no
place, and if anything, is mentioned
here only to be condemned.
II. Ovulation Timing Techniques

Periodic abstinence or rhythm , "the
natural contraceptive method", has survived the centuries because it does
nothing artificial to the body for its efand
thus
offends
no
fectiveness,
religious doctrines . Its inadequacy ,
however , lies in the fact that "all
women are not created equal" at least
insofar as the regularity of their
menstrual cycles and timing of ovulation
are concerned . Modern refinements in
this technique based upon current
knowledge of the menstrual cycle have
somewhat improved upon the efficacy of
this method . These include basal body
temperature charting, assessment of
vaginal pH and cervical mucous changes
(Billing's method) which act as indicators of impending ovulation.
III. Spermicides

Spermicidal agents delivered in the
form of gels, creams and foams which
act as the vehicles, have survived the
test of time. The major substance
employed as the spermicide, regardless
of the vehicle, is nonoxynol-9 . Recent
claims by the manufacturer of one J:lroduct produced in the form of a vaginal
suppository which effervesces upon insertion into the vagina, is an effectiveness rate approaching that of the
oral contraceptives. This statement is far
from true, and in fact, is similar to the
failure rate (pregnancy rate) associated
with the other spermicides.
Insertion of these agents into the
vagina should, for the most effective
results, be no longer than 30 minutes
prior to coitus, and a new application
should preferably be employed with each
subsequent act of intercourse.

IV. Barrier Methods

The condom and the diaphragm too
have survived the modern contraceptive
evolution with little refinement other
than the basic materials from which
they are manufactured.
The major refinements in the condom
have been in the production of a thinner
membrane in order to overcome one of
the major objections of the male consumer , i.e., loss of sensation. However,
this has resulted in an increased incidence of rupture of the condoms with
resultant leakage of the sperm. Furthermore, as was pointed out earlier in the
case of women, "all are not created
equally" similarly "not all men are
created equally". In some cases the condom may slip off, generally after
ejaculation when the erection is lost,
again with resultant leakage of sperm.
Perhaps the major problem associated
with the condom is the fact that it is
often applied too late. If intromission
occurs during the stage of sexual
arousal, and prior to condom application, seminal fluid containing sperm
may be released into the vagina resulting
in pregnancy .
Refinement in the spring or coil of
the diaphragm rim has made proper insertion easier, as have the accompanying
inserters. A spermicidal gel must always
be used in conjunction with the
diaphragm and is applied around the
rim of the device prior to insertion.
Furthermore, the device should be left
in place for eight hours following coitus
and then removed, cleaned, inspected
and stored.
V. Mechanical Contraception
I. Diaphragm
2. Intrauterine Devices

At the beginning of the twentieth century, Ota in Japan experimented with
intrauterine rings of silkworm gut and
later Graafenberg in Germany, developed the intrauterine ring composed of
German silver. Its efficacy later proved
to be largely due to the high content of
copper in this metal alloy.
The "plastic revolution" resulted in
the development of the current first

generation, or non-medicated, IUD's.
of
These devices
were composed
substances such as polyethylene and
were designed in various shapes in order
to achieve less distortion of the uterine
cavity. Their effectiveness depended
largely upon their size since the greatest
contraceptive efficacy was obtained
when a large surface area of the device
was in contact with the endometrium.
The discovery that metal such as copper could enhance the antifertility effect
of the non-medicated devices by a
regular and sustained release of copper
ions into the endometrium enabled the
refinement of the plastic matrix. The
size was then able to be reduced without
sacrificing contraceptive effectiveness.
Further refinements occurred in the
IUD with the development of a membrane which had the property of zero
order release . This led to the production
of a device in which a steriod such as
progesterone could be encased and
released at a predictable daily rate . The
result was the production of an atrophic
endometrium unreceptive to implantation
of the fertilized ovum.
Our current understanding of the
mechanism by which the IUD imparts
its antifertility effect is incomplete.
Theories of increased tubal and uterine
motility producing rapid transit and
subsequent expulsion of the ovum are
no longer accepted . An endometrial inflammatory response due to the presence
of an intrauterine foreign body occurs.
This leukocytosis as well as alteration in
various enzymes such as carbonic
anhydrase seem to produce the antifertility
effect which is further enhanced by the
of the
direct endometrial
effects
progesterone or copper ions .
The evolution from the non-medicated
to the new medicated devices in the past
ten years seems to have succeeded in
providing fairly effective although not
absolute contraception with reasonably
acceptable side effects .
VI. Steroidal Contraceptive
Pharmacologic developments in steroid
synthesis and extensive animal experimentation have provided various
forms of steroidal contraception including oral, injectible and subcutaneous
implants. These agents, primarily the
oral steroids, have and are providing approximately 50 million women throughout the world with effective ongoing
contraception.
No single class or group of drugs has
ever been researched, scrutinized and
criticized more extensively than oral contraceptives.
Originally, levels of 100 micrograms
of estrogen per tablet were felt necessary
to produce the desired antiovulatory effect. With the demonstration of the
relationship between estrogen dosage and
the more serious side effects such as
thromboembolic phenomena, attention
was focused at lowering the estrogen

dosage without sacrificing contraceptive
efficacy.
In the attempt to more closely
simulate the normal hormonal pattern of
the menstrual cycle, the sequential oral
contraceptives were formulated. Estrogen
alone at doses of 75 to 100 micrograms
per day were administered for the first
eleven days of therapy, followed by the
addition of a progestin combined with
the estrogen in the last ten days.
Heavier menses and a significant
breakthrough ovulation rate with resultant increased numbers of pregnancies
were a problem . Furthermore, the
association between such formulation s
and the development of endometrial
hyperplasia and even endometrial carcinoma resulted in their withdrawal as
oral contraceptives.
Formulations containing progestin only were developed in an attempt to
totally avoid the use of estrogen with its
potential side effects. Poor cycle control
(irregular bleeding) and
a higher
pregnancy rate have contributed to a
limited use of this type of medication .
Its major value today is in the patient
where the use of estrogen is contraindicated and yet an oral contraceptive is
desirable , e.g., the lactating patient and
those with a history of estrogen dependent side effects or disease.
Synthesis of more potent progestins
has resulted in the production of oral
contraceptives containing 50 micrograms
and more recently , even 35, 30 and 20
micrograms of estrogen. For many years
the 50 microgram pills were popular and
overcame many of the estrogen-related
side effects. In the last few years the
35, 30 and 20 microgram formulations
have increased tremendously in popularity. However, at the 20 microgram level,
a greater incidence of breakthrough
bleeding and slight decrease in contraceptive efficacy has resulted in limited
use of this formulation. For this reason,
the majority of oral contraceptives
utilized at the sub-50 microgram dosage
level are the 30 and 35 microgram ones.
Although no hard scientific data is
available to support a decreased incidence of side effects with these lower
dosage formulations, it appears that it is
still wiser on the part of the physician
to choose these products as a first
choice.
Subcutaneous implants of long acting
estrogen pellets have had limited use ,
but with good contraceptive effect.
Injectible long acting progestins such
as medroxy-progesterone acetate can be
used for long term ovulation suppression, but may in fact produce excessive
suppression beyond the desired end
point. Amenorrhea results with its use
and at the same time irregular spotting
often occurs. The latter often decreases
acceptability of this potent progestational
agent. Furthermore, the association
between
this
compound
and
the
development of breast tumors in female

beagle dogs has resulted in its withdrawal
for use as a contraceptive agent, although
no association has been demonstrated in
humans .
Other long acting estrogen compounds
have been used as injectible contraceptive
agents, but again with only limited
acceptability.
In summary, continuous reevaluation
has enabled the dosage of the steroids, both
estrogen and progestin, to be reduced to a
minimum without sacrificing contraceptive
efficacy to any great extent, and in some
cases has resulted in a lower incidence of
untoward effects. When well tolerated and
properly taken these preparations provide
almost fool proof contraception for their
users.
VII. Sterilization
In recent years more and more
couples are turning to sterilization as a
means of permanent contraception.
More readily available and simple
techniques have been developed which
have become more universally accessible.
Organizations such as the Association
for Voluntary Sterilization with its
worldwide exposure has done much to
promote education and availability of
sterilization techniques throughout the
world in both developed and lesser
developed countries. Sterilization should
always be considered a permanent procedure.
Couples should never be
counselled on the basis that a sterilization procedure is readily and universally
reversible . Even in the light of today's
surgical skills such as tubal microsurgery, no single procedure can boast
lOOo/o efficacy and 100% simple reversibili ty (which is measured by full term
intrauterine pregnancy) .
Once the decision is made to undergo
sterilization , surgical procedures are
available either for the male or the
female. Further counselling has been
necessary so that the choice between the
male and female procedure can be made
by an informed and knowledgeable couple.
Male Sterilization
Vasectomy: This procedure involves
surgical occlusion, with or without resection, of a segment of the vas deferens.
The advantages to this form of sterilization as opposed to female sterilization
include:
1. Relatively simple surgical technique
to master
2. An out-patient, office or clinic
procedure
3. May be performed under local
anesthesia
4. A low failure rate .
The disadvantages include:
1. The presence of an accessory vas
may result in failure.
2. Follow-up
semen
analysis
is
necessary six to eight weeks
following the procedure to ensure
azospermia.
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3. Possible
psychosexual
complications if the male is not totally
convinced and motivated to have
the procedure-e.g. impotence .
Recent, but as yet preliminary, animal
studies have shown an increased incidence in the development of premature
atherosclerotic
changes
in
animals
undergoing vasectomy as compared to
controls. This is premature and unpublished data and requires a great deal
of further scientific investigation before
any definite conclusions can be drawn.
Female Sterilization
Tubal ligation is generally used to
refer to any form of tubal occlusion
carried out surgically with the aim of
producing permanent sterility. However,
recent experiences in the courts suggests
that a differentiation or distinction
should be made between the terms tubal
ligation and tubal occlusion if for no
other reason than to confirm the patient's informed consent.
1. Hysterectomy: Although hysterectomy
can certainly achieve sterilization, it is
reserved by most physicians for those
women requesting sterilization who have
associated gynecologic pathology, e.g.,
abnormal
Pap
Smear,
menstrual
dysfunction , endometriosis, PID, and
uterine prolapse.
Caesarian hysterectomy is also advocated by some but the morbidity and
mortality rates are too high to consider
such a combined procedure except under
exceptional circumstances.

2. Tubal Sterilization: There are three
major variables in approaching tubal
sterilization. These include the timing of
the procedure in relation to pregnancy,
the route of approach to the fallopian
tubes and finally the method of tubal
occlusion.
•
(i)

Timing
Post partum three to four
days following delivery Interim
(ii) Route of Approach
Abdominal
-Conventional laparotomy
-Mini-laparotomy
Vaginal
-anterior or posterior colpotomy
Endoscopic
-abdominal-laparoscopy
-vaginal-culdoscopy
-transuterine-hysteroscopy
(iii) Method of Occlusion
of
both
1. Complete
resection
fallopian tubes-total salpingectomy.
2. Partial
resection
of
tubesfimbriectomy (Kroener technique)
3. Mid-segment resection (Pomeroy
technique)
4. Others - Uchida, Aldrich, Irving
etc.
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5. Electrocoagulation
-burn only
- burn and transect
- burn and resect
6. Mechanical occlusion
- silastic band (Falope ring)
-clip (Hulka clip)
The two most commonly employed
approaches to interim sterilization are
laparoscopy and mini-laparotomy. Any
of the occlusive techniques may be
employed with the latter approach,
whereas electrocoagulation or one of the
mechanical
occlusive
techniques
is
employed with laparoscopic sterilization.
Failure rates vary with different procedures from 1-7/1000. It appears that
these rates are highest with post partum
procedures or when performed concomitantly with Caesarian section.
Sterilization Reversal
The current rate of 1-20Jo of previously sterilized women requesting reversal
of the procedure appears to point out
two important factors. The first, is the
necessity for more in depth counselling
of the patient, or preferably the couple,
so that they fully understand the implications of their decision. Secondly,
some mechanism, until now non- existent, for selecting those individuals who
will be the ones most likely to return requesting reversal is necessary . It is interesting to note that it does not appear
to be the young nulliparous woman or
the one of low parity who requests
reversal. Once such women as these
make the decision to have a sterilization
they appear to be among the most
highly motivated to maintain their
freedom from fertility for various
reasons. It has been our personal experience that it is the patient with two
or three children who is her late twenties and early thirties who requests the
procedure.
At present, with the state of the art
as it exists, reversal of sterilization requires a full laparotomy , a technically
exacting (often microsurgical) procedure
of two to five hours duration, five to
seven days of post-operative hospitalization, a variable post-operative recuperative period at home, and a success
rate, at best, of 65%. Furthermore, success can only be measured in full term
intrauterine
pregnancies
since
post
operative tubal patency alone does not
imply success of the procedure. As well
the incidence of ectopic (tubal) gestatio~
is increased up to five times following
tubal reanastomosis, i.e., reversal of
sterilization.
For - these reasons, reversal of tubal
sterilization should not be taken lightly
nor encouraged by the physician. Most
of all, couples should never be coerced
into undergoing a sterilization procedure
on the basis of ease of reversibility.
It is beyond the scope of this discussion to deal with other very important
and pressing issues in the realm of con-

traceptive sterilization, namely the mentally retarded patient and the physically
handicapped minor. Suffice it to say,
that there has been enough concern in
these areas, that specific committees
have been established to evaluate current
practice and establish certain guidelines.
Vasectomy reversals are also being requested. Although reanastomoses are
most often possible, restoration of fertility is by no means guaranteed.
VIII. Menstrual Extraction
Menstrual extraction or regulation, is
a technique which has recently come into vogue in some countries. In this
minor office procedure, the uterine cavity of women whose menstrual periods
are delayed for one or two days, is
aspirated with a simple form of suction
apparatus.
Commercially
available
pregnancy tests at their present level of
sensitivity would generally not detect a
pregnancy in such cases. As a result,
this procedure may in fact be an early
abortive procedure and thus subject to
all the criticisms of abortion. When used, it should be as a final resort and
not a means of supplanting acceptable
contraceptive methods.
IX. Abortion
Abortion is mentioned at this point
only for the sake of being complete. In
some countries this procedure functions
as an acceptable and sometimes the only
contraceptive modality. However, in our
society in North America, this author
condemns the use of abortion as an acceptable alternative to ongoing contraception. Most physicians dealing with
contraceptive counselling would agree
that the education of the public regarding contraception, promotion of accessibility and a genuine sympathetic
rapport with the patient is far more
desirable.
X. Post-coital Contraception
This form of contraception has its
major value as an emergency measure to
prevent unwanted pregnancy resulting
from a single unprotected coital exposure, e.g. rape. Estrogens (synthetic,
natural and conjugated) have been
employed successfully in high doses to
prevent
implantation
(interception).
Diethyl-stilbestrol (50 mg. daily for five
days) has been used most extensively for
this purpose with a reported failure rate
of 0.0 to 2.4%. Ethinyl estradiol (2- 5
mg. daily for 5 days) and a conjugated
estrogen (30 mg. daily for 6 days) have
also been employed with failure rates of
0.0 - 1.1 and 0.0 - 1.5% respectively
obtained .
The major disadvantage to such
therapy is the production of nausea and
vomiting. This unpleasant side-effect fre·
que~tly. resu_Its in
negative patient
m?tivatJOn With cessation of treatment
pnor to completion of the entire course
of therapy .

Progestins alone have also been
evaluated as post-coital agents but
primarily as an ongoing method. In
such cases, the progestin is ingested
after each coital exposure. Poor cycle
control as well as method failures have
resulted in a waning of the interest in
this regimen.
A combination of ethinyl-estradiol and
dl-norgestryl has recently been evaluated
for similar purposes and shows promising results both from the standpoint of
efficacy as well as a decrease in side effects.
To date, however, no fool-proof,
oral, post-coital contraceptive agent has
been developed.
Copper-containing intrauterine devices
have been reported to be effective as
post-coital contraceptive agents if inserted within five days of unprotected
coital exposure. The data are still
limited to make any definitive comments
as to the efficacy of such a technique.
Pregnancy (Failure) Rates
A major factor determining the
ultimate pregnancy or failure rate with
any reversible contraceptive method is
patient motivation . The various barrier,
chemical, ovulation timing and oral contraceptive methods require motivation
for their use with every coital exposure.
Thus, improper use or total failure to
utilize the method on any occasion
results in higher failure rates. Only the
intrauterine device requires no ongoing
motivation for its effectiveness, beyond
a single initial motivation to have the
device inserted.
The second consideration is patient
tolerance for side effects and the
nuisance aspect of the method. Since
lack of tolerance for nuisance side effects results secondarily in decrease or
loss of motivation, subsequent pregnancy becomes a reality.
These two factors must be considered
when evaluating the effectiveness of any
contraceptive modality which requires
continuing motivation. Thus, method
failures should be considered separately
from patient failures.
Sterilization failures, however, have
the variables of method failure as well
as, surgical error to contend with. Inadvertent ligation of structures other
than the fallopian tubes or inadequate
occlusion do occur much more frequently than one would wish to acknowledge.
In such cases only visualization of the
tubes in case of a failed sterilization can
establish whether the failure was a
method-related one or a surgical error.
Failure rates for the methods discussed in this section are demonstrated in
l. They appear from
their
Fig.
magnitude in several instances to reflect
the influence of patient failure superimposed upon method failure.
In order to increase consumer motivation attractive packaging has been
employed by manufacturers. In the case

of condoms, the colours of the rainbow
and exotic names have been utilized to
increase the interest of the male or even
his sexual partner.
Combinations of methods such as the
condom or IUD and a spermicide in
motivated individuals has helped to further decrease failure rates to very acceptable or at least tolerable levels.

tion, "John, did you take your pill today?" is still open to question and further clouds the issue. The fact still remains that it is the woman who
becomes pregnant and suffers greatest
from an unwanted pregnancy and thus ,
in many cases by choice, the burden of
contraception has fallen upon her
shoulders.

THE FUTURE
The future of contraceptive evolution
is unlimited. However, when one considers any research dealing with new
contraceptive technology, its worldwide
applicability becomes an extremely important factor . Simple techniques which
can be self administered or delivered
under the supervision of paramedical
personnel, which are of low cost and
have minimal side effects are mandatory
considerations. For example, a method
which produces a high incidence of irregular bleeding would be unacceptable
to certain cultures, especially those
where menstruation precludes the participation of the female in daily activities and perhaps even results in her
banishment to a "menstrual hut".
As far as the male is concerned, some
cultures equate male fertility with virility
and leadership. Thus male contraception
would not be an acceptable alternative
in such cases.
When
one
considers
the
costs
associated with the development of new
contraceptive technology as well as the
ever increasing restrictions established by
governmental drug regulatory agencies,
it appears easier to understand the reluctance on the part of private industry to
pursue large scale investigations .
Political events such as the establishment of cultural and trade exchange
with China has, among other things, exposed the western world to Chinese contraceptive technology. Naturally occurring substances such as Gossypol, a
plant derivative, as well as other herbal
antifertility substances are currently being investigated. Similar herbal extracts
employed as contraceptive agents in
other countries are also being evaluated.

Female Contraception
l . Barriers: Medical reporting in the
various media, at times misinterpreted
or taken out of context, has raised considerable doubts and fears in the minds
of many women with relation to the
oral contraceptives and the intrauterine
device. This has led to the popularization of research in barrier methods . One
of the more promising of the methods
appears to be the intravaginal sponge
composed of polyethylene or collagen.
Studies to date, however , suggest that it
is necessary to incorporate a spermicidal
agent into the sponges in order to
achieve acceptable antifertility rates. The
sponge is left in the vagina for several
days and removed by the patient,
cleansed and reinserted . Unpleasant
odours and as yet unproven efficacy
rates have prevented their large scale use
until now.

Male Contraception
Reversible methods of male contraception are currently being evaluated.
However , no major breakthrough appears to be on the horizon.
Suppression of spermatogenesis has
been achieved with various chemical
substances, both natural as well as synthetic. The major problem encountered
with such methods involves either a concomitant suppression of normal steroidogenesis or failure of reversal of spermatogenesis once the medication is
withdrawn.
However, the search for a male contraceptive agent or "male pill" continues. The question as to how the
female partner would accept or rely
upon a positive response to her ques-

2. Mechanical devices:
(a) The intracervical device (lCD) is a
small structure composed of a plastic
polymer which is inserted into the cervical canal as opposed to the uterine
cavity. If this were possible, then the
device could be envisaged as a carrier
of
various
vehicle
for
delivery
substances to the cervix, vagina and
even the uterine cavity and thus affect
conception, e.g., spermicide, steroids,
immunologic agents etc.
Expulsion, cramping, pain and cervical perforation have been until now ,
the major stumbling blocks in the pursuit of this avenue of contraception.
(b) New configurations of intrauterine
devices or old shapes covered by metals
or encapsulating synthetic steroids for
sustained release over long periods of
time are also being evaluated. Similar
problems as with existing intrauterine
devices appear to plague these new
developments, e.g., CUT 220, Multiload,
long
acting
progesterone
releasing
device.
3. Steroidal contraception: Delivery
systems as opposed to new steroid synmajor
thesis
appear
to
be
the
developments being evaluated .
(a) Vaginal Rings: Zero order steroid
release can be obtained from a
polymeric ring much the same way that
progesterone is released from the progesterone containing IUD . The ring
which is being evaluated is approximately 60 mm. in diameter and resembles
the outer rim of a diaphragm except
that it is thicker.
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The ring is inserted into the vagina,
left in place for 21 days and then
removed and rinsed clean. After seven
days during which time the woman
menstruates, the ring is reinserted.
The steroid which is released from the
ring is absorbed through the vaginal
mucosa and acts by suppressing ovulation in the same fashion as the oral
contraceptives. The major advantage to
the ring over the oral medication is that
it does not require daily motivation for
its use once it is inserted. Furthermore,
studies with one of the rings containing
two specific steroids, the metabolic
changes appear to be less than those
seen with the oral contraceptives .
If dyspareunia were to occur due to
the presence of the ring, it can be
removed during intercourse and then
replaced.
These vaginal rings appear to carry
considerable promise as to their applicability and acceptability for future
use as a contraceptive agent on a
worldwide basis.
(b)
Encapsulated
microspheres :
Biodegradeable microspheres have been
produced into which steroid can be incorporated and released at varying rates .
These microspheres are administered by
injection and thus have the potential of
resulting in a once a month or even less
frequent injection for contraceptive purposes .
The advantage to this method includes
the fact that again, it requires only occasional motivation for administration,
i.e., one to twelve ;njections per year.
However, the disadvantage with this
method rests with the fact that it does
require injection and therefore requires
some degree of trained personnel for administration. Furthermore, once injected,
the medication cannot be removed from
the body and therefore poses all of the
problem which can be . associated with
the injection of any long acting
substance if untoward effects occur .
4. Luteolytic Agents: Destruction of the
corpus luteum on a regular monthly
basis would assure loss of hormonal
support of a pregnancy if it were to
have occurred in any cycle. A monthly
administration of a Iuteolytic agent
would therefore result in corpus Iuteum
destruction and the onset of withdrawal
menses. This in fact results in an abortifacient method as opposed to an antifertilization one. The prostaglandins
and their analogues have been shown to
be extremely effective luteolytic agents
in animals and experimentation in
humans is progressing along similar
lines.
Prostaglandins have also been used
for early pregnancy termination in the
form of vaginal suppositories. Extensive
side effects with many of the prostaglandin derivatives do occur, although
these can be minimized or alleviated
with the use of some of the new
analogues.
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5. Immunologic Contraceptive Techniques: Animal experimentation has
shown that the concept of immunizing
the female against pregnancy is definitely feasible. The major advantage of
such a technique is the freedom which it
provides of frequent or even daily administration, eliminating the hazards or
side effects of such frequent exposure.
On the other hand, such a concept introduces other problems which are at
present not fully understood including
of
method
reversibility,
outcome
failures, duration of effectiveness, influence on subsequent fertility , safety
and widescale applicability.
The immunologic approach to contraception depends upon the body's
ability to protect itself from pregnancy
in much the same way as it defends
itself against bacterial infection . Such an
approach may be directed at various
stages in the reproductive process and
may be accomplished by either active or
passive immunization. The latter form is
shortlived since it relies upon exogenous
antibody administration and thus its activity lasts only as long as the biological
life of the antibody.
Active immunization procedures are
therefore the ones which hold promise
as large scale contraceptive possibilities.
It has been suggested that the ideal
qualities of an antifertility vaccine
would include :
I -that it be universally effective;
2 - intermediate in action
(6-24 months)
3- totally reversible, and
4- devoid of side effects.

Specific Immunologic Areas of
Investigation
A) Immunization Against HypothalamicPituitary or Gonadal Hormones
Although the trophic hormones of the
hypothalamus
and
pituitary
are
necessary for gamete development, interference with their producti,on or effects results in undesirable side effects
such as menopausal symptoms, loss of
libido, etc. Similar effects result with
immunization against any of the gonadal
hormones. This avenue of approach is,
therefore, unlikely to provide the solution to immunologic contraception.
B) Immunization Against Spermatazoa
Immunization against various sperm
specific antigens such as those of the
acrosomal cap, the midpiece or the tail
are being evaluated. To date, however,
only partial immunity has been achieved
when such antigens have been administered to the female.
C)
Immunization
Against
Female
Reproductive Tract Antigens such as the
ovum (zona pellucida), embryo and
placenta specific antigens are currently
being evaluated as potential targets for
immunologic contraception. These sites
appear to be the most promising at present for future immunologic contraceptive
development.
6. Reversible Sterilization Procedures:
Male:
Intravasal plugs of various shapes,
sizes and materials which can occlude
the lumen of the vas and later be
removed have been and are currently being evaluated. Their major disadvantages

430 Richmond Street/Telephone 672-4720

lies in the inability to obtain tissue ingrowth from the vas into the plug in
order to stabilize it. The plug can
therefore shift, resulting in the passage
of seminal fluid beyond the plug, and
subsequent failure.
The ability to invert a valve much like
a tap which could be turned on and off
to allow the passage alternating with
obstruction of seminal fluid flow has
been the aim of many researchers. To
date, no one has been able to produce
an adequate mechanical occlusive vasal
device.

the early follicular phase of the cycle.
Sophisticated endoscopic equipment such
as the hysteroscope makes this procedure expensive both from the standpoint of purchasing as well as
maintenance.
The reversibility of such a procedure
is still yet unproven and is in the early
human stages of investigation at the present time. If the techniques do prove to
be feasible, it could then be carried out
under local anaesthesia in a clinic setting.

Female:

b) Tubal Covers or Hoods
Various forms of fimbria! covers have
been developed and are continuing to be
developed, which would act much like a
"condom" over the fimbriated end of
the tube preventing entry of the ovum .
The problem which is currently being
encountered is to find a hood which can
be held in place over the fimbriated end
of the tube and at the same time allow
for transudation of tubal fluid through
it so that a hydrosalpinx will not
develop. The fimbria! covers which are
currently being evaluated require a minilaparotomy incision and suturing in
place with at least four stay sutures .
This requires the use of magnification
by loop glasses so that a very fine
suture can be utilized which would produce less tissue reaction in the serosa of
the tube and thus fewer adhesions .

a) Hysteroscopically Directed Tubal
Plugs
Small plugs of metal alloy and silastic
are being evaluated for occulusion of
the tubal ostia with a view to subsequent removal and re-establishment of
fertility . These plugs are delivered by
means of a hysteroscope into the uterine
cavity.
A major disadvantage to a procedure
such as this, is the necessity for an experienced hysteroscopist to carry out the
procedure. Furthermore, even though the
hysteroscope is inserted into the uterine
cavity through the cervix, the tubal ostia
can only be visualized in approximately
85o/o of cases. The amount of endometrium present in the uterine cavity
can also effect the visualization and
therefore the timing of the procedure is
critical in that it should be performed in

CONCLUSION
Whenever one deals with the topic of

conception and its prevention, science
must come to grips with religious , moral
and ethical considerations as well. The
concept of effective and readily available
contraception has been earmarked as a
"loose
morals"
and
licence
for
"promiscuity" by many. The validity of
this statement is somewhat open to
question. Perhaps however it is an easy
way of covering up our deficiencies as
parents in shaping the moral and ethical
standards of our children.
There is currently no single ideal contraceptive method available. As a result,
the choice of any method must be based
upon careful consideration of each individual case. The past medical and
family histories must be evaluated and
the patient's fears, anxieties and apprehensions regarding each method considered. Only then can the risks for
each method be weighed against the
benefits to the individual. Selection of a
contraceptive method can then be made
by an informed patient with the
guidance of her physician .
Numerous avenues of new contraceptive techniques are being investigated in
centers throughout the world . The ideal
contraceptive still appears to be in the
distant future. Until then, we must
utilize the methods which are available
to us and at the same time assure
ourselves that the patient has adequate
counselling and understands fully the
implications of her final decision .

FAILURE RATES* WITH VARIOUS BIRTH CONTROL METHODS

TUBAL STERILIZATION
VASECTOMY
ORAL CONTRACEPTIVES
I.U.D .
CONDOM
DIAPHRAGM
CHEMICAL SPERMICIDES
WITHDRAWAL
RHYTHM
NO METHOD

0- 0.02
0- 0.02
0- 0 . 1
2- 4
10- 14
12- 15
4-29
20-38
14-47
60- 80

*Number of pregnancies expected per 100 couples using the method for one year.
References - Rx Bulletin 1970
British Medical Bulletin
FDA Consumer 1977
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The Seven Year Itch
by Dr. J. V. Frei
Primary biliary cirrhosis (PBC) is a
very rare fatal disease. According to
Dame Sheila Sherlock there were 165
deaths certified as due to it in England
and Wales in 1967-71'. That means that
approximately I in 50,000,000 people
will die of this disease assuming that
half of the deaths will be undiagnosed .
Or to put it another way there should
be about 80 such deaths in Canada in a
5 year period. The average prognosis
from the time of diagnosis is probably
at present about 7 years 2 , so there
should be 560 such patients in Canada
at any one time. In 5 years the University Hospital , Lodon, Ontario , has
made the diagnosis 16 times or about 3
new cases a year. A physician in general
practice is not likely to see one case in
his career.
Nevertheless it is a fascinating disease
characterised usually by an insidious
onset of relentless pruritus in nearly 4/ 5
of the cases (Table 1). What is this irrepressible itch due to? As with so
many diseases of obscure aetiology ,
when we don't know we suspect and
speculate. At the time of diagnosis the
characteristic lesion is a destruction of
cholangioles in the portal triads in the
midst of a dense spherical lymphocytic
infiltrate. Sometimes a few epithelioid
cells forming a granuloma are present
(911Jo of cases only). An alternative name
for the disease is more accurate but
more of a mouthful: chronic nonsuppurative destructive cholangitis. Why
the bile ductules are seemingly attacked
by lymphocytes is not known. There are
several reasons, some g1vmg useful
diagnostic tests, why an immunological
attack on the cholangioles is suspected.
The main one is that 80-90% of the patients have circulating antibodies against
mitochondria (AMAs) while normal people have none and people with another
chronic liver disease, chronic active
hepatitise, have AMAs in only 30% of
cases 3 • This is probably an IgM which
is often elevated and histochemically
similar material can be seen in the lesion. Relatives of patients with PBC
tend to have PBC more often and an
increased incidence of circulating abnormal antibodies of various sorts• but
if it is an "autoimmune" disease, then
unlike other autoimmune diseases it is
not associated with any particular HLA
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transplantation antigen or ABO or
Rhesus blood group 5 6 •
Because of the interest in narrowing
down the prognosi s attempts were made
to "stage" the progress of the disease
by a liver biopsy with moderate success7 "· As many such progressive inflammatory diseases, it develops from a
degenerating duct cell under attack by
antibodies or by lymphocytes, to cell
necrosis, chronic or chronic granulomatous inflammation (Fig. 1) , to healing
by fibrosis and eventually to demonstrate
cirrhosis.
The
lesions
are
multifocal but develop more or less
simultaneously, so that a degree of staging is possible on the basi s of morphological progression of the disease .
For the purposes of diagnosis , the
hallmark is a liver with a striking paucity of bile ductules in portal triads, with
occasional round foci of lymphocytes
there, and often very slender fibrous
septa connecting portal areas in the cir_rhotic s ta~e .
Given the disappearance of bile ductules, the symptomatology can be
reasonably well accounted for. There is
intrahepatic biliary obstruction in the
first
instance,
with
pruritus
predominating for unknown reasons . Jaundice and hypercholesterolaemia with xanthelasmas are also common. In this
is
stage the alkaline
phosphatase
elevated in the serum disproportionately
to liver enzymes, as expected. There
may be steatorrhoea and malabsorption .
In the cirrhotic stage liver failure adds
its symptomatology with such hormonal
effects as amenorrhoea , acne and hirsutism . A bleeding tendency because of
hypoprothrombinaemia or from varices,
and anaemia of hypersplenism also occur. In other words PBC is one of the
possibilities in obscure cirrhosis.
This disease involves women in
85-90% of cases, for no known reason.
Our own cases show 13 women and 3
men. The average age is 50. In our 16
cases the average age at diagnosis was
55 with a range from 39 to 68 years. It
is generally accepted that the disease
progresses relentlessly to death . Dame
Sherlock 2 reports 35 cases followed from
diagnosis to death, for an average interval from diagnosis to death of 5 V2 years
with a wide range between 3 and 11
years. More recent literature suggests a

TABLEt
PRESENTATION OF PRIMARY
BILIARY CIRRHOSIS 2
OJo

Pruritus
Pruritus
Icterus
Cirrhosis
Abnormal Jab test
Other

57
20
8
7
4
4

slightly better prognosis as anecdotally
many cases live for more than 10 years.
This could be due to earlier diagnosis,
or changing criteria of diagnosis, or the
detection of subclinical cases. It is
because of that that perhaps a seven
year survival is at present a realistic
average- the seven year itch.
-the seven year itch.
The treatment of all diseases of
unknown aetiology tends to be unsatisfactory. Unlike some autoimmune
diseases, PBC does not generally respond well to steriods, may even perhaps
be accelerated by them. Nothing can be
done, it seems, to affect the course of
the disease, so therapy is aimed more at
the prominent bothersome symptom,
pruritus. As the biliary obstruction,
while marked, is obviously incomplete,
the aim is to interrupt the enterohepatic
circulation and prevent the reabsorption
of whatever it is that causes the
pruritus . Oral cholestyramine and if
more drastic measures are required, the
creation of a biliary fistula to the outsi de have had a modicum of success 9 in
treating pruritus in cases of the seven
year itch.
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Letter to the Editor
Dear Editor,
I would like to correct a statement made by Maureen McConnell in "Hippocratic Council News" (Vol. 49, No.1, March, 1979).
The increase in clerkship stipend from $1200 to $1500 was engineered by the
O.F.M.S.S. (Ontario Federation of Medical Student Societies), and not the
S.S.O.M.A.
The S.S.O.M.A. was certainly very helpful in preparing a comparative survey
of medical student funding across Canada and it was armed with this survey and
other facts, figures and arguments, that Anne Fleming (President U. of T.M.S.S.)
and I met with Mr. Timbrell last fall.
That meeting closed with an undertaking by O.F.M.S.S. to provide current
year (1978-79) statistics on funding and with an undertaking by the Ministry to
meet with us again to discuss the amount, if any, of the increase. Shortly
thereafter an increase of $300 was announced although it has remained the intention of the O.F.M.S.S. to proceed according to the understanding of our first
meeting with a view to a total increase of at least $600 - the figure which more
nearly approaches the shortfall between available funding and need.
Yours very truly,
Jeff Coleman. Meds '79
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